Official UK procurement notice
Labs Managed Service Contract (Extension)
Authority: NHS Lanarkshire (NHS & healthcare)
What is being bought
Published requirement descriptionExtension to current Labs Managed Service covering all disciplines
CPV: Laboratory services
The lotProcurement structure
single lot · no lot value publishedLot #1Extension to current pan-pathology Labs Managed Service Contract at all sites as…Awarded
Extension to current pan-pathology Labs Managed Service Contract at all sites as preparation work for new contract had to be put on hold due to diversion of resource to deal with Covid situation
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 15 Feb 2021, 10:48 GMT
- Last source update
- 15 Feb 2021, 10:48 GMT
- Authority reference
NHSL 78- FTS notice number
2021/S 000-002999- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02931eFind a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
The Board was preparing a statement of requirements and specification which were necessary pre-requisites for the procurement exercise, in the run up to the expiry of the current contract which is due to end on 6th February 2021. However, because of the necessary response to Covid-19, clinical and support services resources (finance, procurement and others) required for the preparation of these key documents have been diverted, and with no definitive date when we will be back to business as usual to recommence this work, an extension to the current contract from 7th February 2021 until 31st March 2022 will provide the additional time to make necessary preparations. Due to diversion of key resources, the Board are not currently in a position to engage with the market and must take this action as a reasonable and proportionate step in order to maintain business continuity with provision of the labs managed service (a critical clinical service at any time, but especially so at the present time) with the current provider.
Publisher note: (SC Ref:644301)
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| ROCHE DIAGNOSTICS LIMITED | £6,500,000 † | — | Awarded |
Contracts
Contract 002999-2021-NHSL 78-1 · ROCHE DIAGNOSTICS LIMITED
- Signed
- 5 Feb 2021
- Value
- £6,500,000
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids · 1 electronic · 1 from abroad | 0 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Hamilton Sheriff CourtReview body
Bidders & participating suppliers
1 commercial party on the notice- Roche Diagnostics LtdAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.